Table 2.

Dosimetry values

PTV
V100 (%)	89.20 (68.56–96.30)
V95 (%)	96.43 (79.39–99.60)
V110 (%)	13.30 (3.02–34.98)
Max point dose, Gy (RBE)	58.84 (50.8–70.5)
Heart (left-sided tumors, n=27)
Mean dose, Gy (RBE)	1.0 (0.09–3.20)
V20 (%)	1.16 (0–6.0)
V5 (%)	5.00 (0.17–14.40)
Max point dose, Gy (RBE)	22.80 (2.48–43.70)
Lungs
Total V20 (%)	7.31 (0.14–13.2)
Ipsilateral V20 (%)	16.50 (6.1–30.3)
Ipsilateral V5 (%)	34.35 (22.5–53.8)
Contralateral V5 (%)	0.34 (0–5.30)
Contralateral breast
Mean dose, Gy (RBE)	0.29 (0.03–3.50)
V5 (%)	1.46 (0–9.90)
Spinal cord
Max point dose, Gy (RBE)	1.24 (0–28.1)
Esophagus
Mean dose, Gy (RBE)	7.50 (0–19.59)
V30 (%)	10.80 (0–37.0)
V40 (%)	3.40 (0–28.9)
Max point dose, Gy (RBE)	45.65 (0–65.4)

Abbreviation: RBE = relative biological effectiveness.

Values are median (range).